What is Global Mesenchymal Stem Cells Market?
The Global Mesenchymal Stem Cells Market is a vast and dynamic field that focuses on the commercialization and utilization of mesenchymal stem cells (MSCs). MSCs are multipotent stromal cells that can differentiate into a variety of cell types, including osteoblasts (bone cells), chondrocytes (cartilage cells), myocytes (muscle cells), and adipocytes (fat cells). These cells are primarily found in the bone marrow but can also be isolated from other tissues such as cord blood, peripheral blood, fallopian tube, and fetal liver and lung. The global market for these cells has been growing steadily due to their potential in regenerative medicine and tissue engineering. The market encompasses various aspects such as the production, sales, and use of MSCs in different therapeutic areas. However, the market is also subject to stringent regulations and ethical considerations due to the nature of stem cell research.
Human MSC, Mouse MSC, Rat MSC, Others in the Global Mesenchymal Stem Cells Market:
The Global Mesenchymal Stem Cells Market is segmented based on the source of the cells, namely Human MSCs, Mouse MSCs, Rat MSCs, and others. Human MSCs are the most commonly used in research and clinical applications due to their high differentiation potential and compatibility with human tissues. Mouse and Rat MSCs are primarily used in preclinical studies to understand the biology of these cells and their potential therapeutic applications. Other sources of MSCs include pigs and primates, which are used in specific research contexts. Each of these segments has its unique market dynamics influenced by factors such as the availability of the source, the ease of isolation and cultivation of the cells, and their relevance to human disease models.
Research Institute, Hospital, Others in the Global Mesenchymal Stem Cells Market:
The Global Mesenchymal Stem Cells Market finds its applications in various areas such as Research Institutes, Hospitals, and others. Research Institutes are the primary consumers of MSCs as these cells are extensively used in basic and applied research in regenerative medicine, tissue engineering, and stem cell biology. Hospitals also use MSCs for various therapeutic applications such as the treatment of bone and cartilage defects, cardiovascular diseases, and autoimmune disorders. Other users of MSCs include biotechnology companies, pharmaceutical companies, and contract research organizations that use these cells for drug discovery, toxicity testing, and cell therapy development.
Global Mesenchymal Stem Cells Market Outlook:
The Global Mesenchymal Stem Cells Market outlook reveals that the market was valued at US$ 217.2 million in 2022 and is expected to reach US$ 282.9 million by 2029, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2023-2029. The market is dominated by three major manufacturers, namely Lonza, Thermo Fisher, and Bio-Techne, which collectively hold about 56% of the market shares. The largest consumer of MSCs is the North America region, accounting for nearly 41% of the sales revenue. Europe follows closely, with a sales revenue market share of about 31%. These figures indicate the significant demand for MSCs in these regions, driven by the robust research activities and the growing adoption of cell-based therapies in healthcare.
| Report Metric | Details |
| Report Name | Mesenchymal Stem Cells Market |
| Accounted market size in 2022 | US$ 217.2 million |
| Forecasted market size in 2029 | US$ 282.9 million |
| CAGR | 4.5% |
| Base Year | 2022 |
| Forecasted years | 2023 - 2029 |
| Segment by Type |
|
| Segment by Application |
|
| By Region |
|
| By Company | Lonza, Thermo Fisher, Bio-Techne, ATCC, MilliporeSigma, PromoCell GmbH, Genlantis, Celprogen, Cell Applications, Cyagen Biosciences, Axol Bioscience |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
